Biopharmaceuticals
The Biopharmaceuticals sector is operating in uncharted waters. Company formation has been close to its peak, while available talent is facing one of its biggest shortages since our team began recruiting in this industry in the early 1990s. Through our years of experience specializing in this industry segment, proven track record, and extensive network with today’s leaders in this space, we are able to partner with our clients to recruit exceptional management teams and Boards of Directors.
Our Team
Hanna Im-Lee
BIOPHARMACEUTICALS
Overview
Our team is focused on the recruitment of Board Members, CEOs and executive leaders across all major functional disciplines, including commercial, finance, corporate development, human resources, R&D, medical, regulatory and technical operations. Our clients are innovative emerging and established therapeutics companies leading the way towards the discovery, development and commercialization of cutting-edge medicines to treat critically ill patients. We work with organizations at every stage of corporate formation and evolution: from startup through commercialization, private to public, and across all therapeutic areas and modalities.
Stealth Mode Companies
We partner with companies at their earliest stages of development to build out leadership teams, expanding upon the expertise of the original scientific founders, and adding competencies throughout the entire C-level. We understand how to attract seasoned industry leaders to complement the scientific luminaries who form this sector’s most exciting companies.
Private to Public
As our clients prepare for their IPOs, we engage with them regarding Board and management team evolution, always with an emphasis on creating and fostering greater diversity in knowledge, perspective, experience and background.
R&D to Commercial
We are retained when companies are planning to grow beyond a purely R&D focus into a fully integrated, commercial enterprise. We have demonstrated expertise identifying executives who will successfully lead through this transition, develop increased organizational capabilities and scale, and help to create a collaborative, cross functional, efficient and culturally aligned team.
Investors
We work with today’s leading venture, family office and private equity investors to build their biopharma portfolio companies and bring transformative science from the laboratory to patients.
News
BIOPHARMACEUTICALS
Frontier Medicines Announces the Recruitment of Andrew Krivoshik, MD, PhD, as Chief Medical Officer
BIOPHARMACEUTICALS
Protagonist Therapeutics Appoints Accomplished Hematologist-Oncologist, Arturo Molina, MD, MS, FACP, as Chief Medical Officer